October 13, 2025

Cultivating Lithuania’s “Entrepreneurship Gene”

Jekaterina Kalinienė, Head of BioTech Lab, Innovation Agency Lithuania, discusses the art of bringing business, academia, and government together.

The Medicine Maker

October 10, 2025

Lobular Breast Cancer Rates Rising Nationwide, Study Shows

Lobular breast cancers present larger, HR-positive tumors and lower long-term survival rates.

Conexiant

October 08, 2025

AEC-MS Enables Robust Analysis of Polar and Ionic Metabolites

A new protocol provides a practical solution for large-scale metabolomics, linking molecular pathways to health and disease 

The Analytical Scientist

October 06, 2025

The Golden Age of Drug Discovery

Sitting down with Insmed’s Tom Heightman, we discuss new technologies for drug discovery and the promise of human genome sequencing data.

The Medicine Maker

October 03, 2025

Study Shows That After Early Breast Cancer Diagnosis, Risk of a Second Cancer Is Low

Researchers followed over 475,000 women diagnosed with early breast cancer from ages 20 to 75 who underwent surgery to track their risk of a second primary cancer as compared to the risk of the genera...

The ASCO Post

October 03, 2025

Does Early Pesticide Exposure Lead to Higher Mortality Risk in Pediatric ALL?

“This study highlights that exposures in the home environment, even before a child is born, may have lasting effects on survival after a leukemia diagnosis. While more research is needed, the findings...

The ASCO Post

October 03, 2025

SciX 2025: Our Picks from the Program

We bring you highlights from SciX 2025, which takes place at the Northern Kentucky Convention Center (October 5–10)

The Analytical Scientist

October 02, 2025

Inside Sandoz’s Manufacturing Vision

We speak with an expert from Sandoz about the need to boost biosimilar manufacturing capacity in Europe.

The Medicine Maker

October 02, 2025

A New Hub for Liver Research Tackles Its First Investigations

Mount Sinai's newly launched Institute for Liver Research has funded its first two pilot projects, chosen from among 11 applications submitted by basic, translational, or clinical research teams, and awarded one-year grants of $30,000 each in hopes of generating preliminary data sufficient to stimulate broader funding and research collaborations. One project focuses on genomics and genetic sequencing of patients to determine how many and which abnormalities are linked to liver disease, while the other proposes to develop a lipid nanoparticle platform for hepatic stellate cell-specific drug delivery.

Mount Sinai New York